Apoptotic effects of imidazo[1,2-a]pyrazine derivatives in the human Dami cell line

European Journal of Pharmacology

Volumn 320, Issue 2-3, 1997, Pages 215-221

  Zurbonsen, Katja ^a   Michel, Alain ^b   Bonnet, Pierre Antoine ^b   Gannoun Zaki, Leila ^a   Mathieu, Marie Noëlle ^a   Chevillard, Claude ^a  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Apoptosis; cAMP; Imidazo 1,2 a pyrazine derivative; Megakaryoblastic cell, human; Phosphodiesterase; Purinoceptor

Indexed keywords

3 BROMO 8(METHYLAMINO)IMIDAZO[1,2 A]PYRAZINE; 6 BROMO 8 METHYLAMINOIMIDAZO[1,2 A]PYRAZINE 2 CARBONITRILE; 6 BROMO 8(ETHYLAMINO)IMIDAZO[1,2 A]PYRAZINE; ADENOSINE; CYCLIC AMP; IMIDAZOPYRAZINE DERIVATIVE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PURINE RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; MEGAKARYOBLAST; PRIORITY JOURNAL;

ADENOSINE; APOPTOSIS; CELL DIVISION; CYCLIC AMP; DNA; DNA DAMAGE; HUMANS; IMIDAZOLES; ISOENZYMES; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PYRAZINES; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2; TUMOR CELLS, CULTURED;

EID: 0031565278     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00890-4     Document Type: Article

References (29)

1. Aharoni, D., A. Dantes, M. Oren and A. Amsterdam, 1995, cAMP-mediated signals as determinants for apoptosis in primary granulosa cells, Exp. Cell Res. 218, 271.
2. Binder, C. and W. Hiddemann, 1994, Programmed cell death - many questions still to be answered, Ann. Hematol. 69, 45.
3. Boe, R., B.T. Gjertsen, S.O. Doskeland and O.K. Vintermyr, 1995, 8-Chloro-cAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) line, Br. J. Cancer 72, 1151.
4. Bonnet, P.A., A. Michel, F. Laurent, C. Sablayrolles, E. Rechencq, J.C. Mani, M. Boucard and J.P. Chapat, 1992, Synthesis and antibronchospastic activity of 8-alkoxy- and 8-(alkylamino)imidazo[1,2-a]-pyrazines, J. Med. Chem. 35, 3353.
5. 3H]NECA in rat striatal membranes, Mol. Pharmacol. 29, 331.
6. Cook, S.J., K. Archer, A. Martin, K.H. Buchheit, J.R. Fozard, T. Müller, A.J. Miller, K.R.F. Elliot, R.W. Foster and R.C. Small, 1995, Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40, Br. J. Pharmacol. 114, 143.
7. Decker, T. and M.L. Lohmann-Matthes, 1988, A quick and simple method for the quantification of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity, J. Immunol. Methods 115, 61.
8. 336→Asp) subunit of cAMP kinase I in a rat leukemia cell line, J. Biol. Chem. 268, 8332.
9. Duvall, E. and A.H. Wyllie, 1986, Death and the cell, Immunol. Today 7, 115.
10. Greenberg, S.M., D.S. Rosenthal, T.A. Greeley, R. Tantravahi and R.I. Handin, 1988, Characterization of a new megakaryocytic cell line: the Dami cell, Blood 72, 1968.
11. Kizaki, H., K. Suzuki, T. Tadakuma and Y. Ishimura, 1990, Adenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavage, J. Biol. Chem. 265, 5280.
12. 2 purinoceptor-mediated responses, Eur. J. Pharmacol. 217, 217.
13. Lanotte, M., J.B. Riviere, S. Hermouet, G. Houge, O.K. Vintermyr, B.T. Gjertsen and S.O. Doskeland, 1991, Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate-kinase I in a myeloid leukemia cell line, J. Cell. Physiol. 146, 73.
14. Laurent, F., T. Pocock, K.R.F. Elliot, K. Portet, V. Benezech and O. Vitse, 1996, Relaxant and phosphodiesterase inhibition activities of imidazo[1,2-a]pyrazine derivatives, Fundam. Clin. Pharmacol. 10, 65.
15. Mentz, F., H. Merleberal, F. Ouaaz and J.L. Binet, 1995, Theophylline, a new inducer of apoptosis in B-CLL: role of cyclic nucleotides, Br. J. Haematol. 90, 957.
16. Michel, A., F. Laurent, J.P. Chapat, M. Boucard and P.A. Bonnet, 1995, Pharmacological activities of imidazo[1,2-a]pyrazine derivatives, Arzneim.-Forsch./Drug Res. 45, 1288.
17. Mühl, H., D. Nitsch, K. Sandau, B. Brüne, Z. Varga and J. Pfeilschifter, 1996, Apoptosis is triggered by the cyclic AMP signalling pathway in renal mesangial cells, FEBS Lett. 382, 271.
18. Pocock, T.M. and R.C. Small, 1996, Studies of the effects of SCA40 in relaxing bovine trachealis muscle and in inhibiting isoenzymes of cyclic nucleotide phosphodiesterase, Br. J. Pharmacol. 117, 209P.
19. 3H]2-MeS-ADP on megakaryocytoblastic cell lines in culture, Biochem. Pharmacol. 48, 83.
20. Sen, S. and M. D'Incalci, 1992, Apoptosis: biochemical events and relevance to cancer chemotherapy, FEBS Lett. 307, 122.
21. Smets, L.A., 1994, Programmed cell death (apoptosis) and response to anti-cancer drugs, Anti-Cancer Drugs 5, 3.
22. Tallarida, R.J. and R.B. Murray, 1981, Manual of Pharmacologic Calculation with Computer Programs (Springer-Verlag, New York, NY).
23. Tanaka, Y., K. Yoshihara, M. Tsuyuki and T. Kamiya, 1994, Apoptosis induced by adenosine in human leukemic HL-60 cells, Exp. Cell Res. 213, 242.
24. Thompson, W.J., W. Terasaki, P.M. Epstein and S.J. Strada, 1979, Assay of cyclic nucleotide phophodiesterase and resolution of multiple molecular forms of the enzyme, Adv. Cyclic Nucleotide Res. 10, 69.
25. Ueda, N. and S.V. Shah, 1994, Apoptosis, J. Lab. Clin. Med. 124, 169.
26. Vintermyr, O.K., B.T. Gjertsen, M. Lanotte and S.O. Doskeland, 1993, Microinjected catalytic subunit of cAMP-dependent protein kinase induces apoptosis in myeloid leukemia (IPC-81) cells, Exp. Cell Res. 206, 157.
27. 1/S transition in mammary carcinoma cells (MCF-7), Endocrinology 136, 2513.
28. Vittet, D., C. Duperray and C. Chevillard, 1995, Cyclic-AMP inhibits cell growth and negatively interacts with platelet membrane glycoprotein expression on the Dami human megakaryoblastic cell line, J. Cell. Physiol. 163, 645.
29. Zurbonsen, K., C. Chevillard, D. Vittet, P.A. Bonnet and A. Michel, 1994, Inhibition of human erythroleukemia (HEL) cell proliferation by imidazo[1,2-a]pyrazine derivatives, Fundam. Clin. Pharmacol. 8, 260.